Deep learning model identifies novel antibiotic compounds effective against drug-resistant gonorrhea
By
James J. Collins
The bagel they save for the regulars. Don't skim, savour.
Summary
This article describes a study where researchers developed and validated a deep learning model to discover new antibiotics effective against Neisseria gonorrhoeae, a pathogen that has developed increasing resistance to all recommended treatments. The model explored chemical space for molecules predicted to inhibit N. gonorrhoeae growth, leading to the identification of two selective compounds with novel chemical structures that showed in vitro efficacy against multidrug-resistant strains.
Key quotes
· 3 pulledNeisseria gonorrhoeae, a well-known cause of sexually transmitted disease, has grown increasingly treatment resistant, and identifying effective ways to tackle this pathogen is an utmost priority.
Anahtar et al. developed and validated a deep learning model before using it to explore chemical space for molecules predicted to inhibit N. gonorrhoeae growth.
The authors chose for further testing two selective compounds with chemical structures different from known antibiotics that also showed in vitro efficacy against multidrug-resistant N. gonorrhoeae.
You might also wanna read
Rockefeller University researchers discover hundreds of new bacteria and two potential antibiotics in soil using DNA sequencing
Researchers at Rockefeller University have developed a method to access the genetic material of soil bacteria that cannot be cultured in a l
GPT-5.4 helped drive a medicinal chemistry project from literature review to a validated experimental result. Paired with Maria AI and specialized lab, the model proposed an unexpected way to improve
WHO Report: Antibiotic Resistance Growing Faster Than Expected, Causing 1.2 Million Annual Deaths
A new WHO report reveals that antibiotic resistance is growing at an alarming rate, with antimicrobial resistance already responsible for ap
Reflections on 2024 Bio-ML Predictions: Generative Chemistry and Molecular Dynamics Challenges
The article reflects on the author's 2024 predictions about bio-ML (biological machine learning) from a 2026 perspective, focusing on genera

AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
The article discusses recent advancements in AI-driven drug discovery, highlighting two key developments: 1) Analytica 2026, an event focuse
Harmonic Discovery: AI-powered platform for precision drug design launches on Product Hunt
Harmonic Discovery is a biotech platform that uses machine learning and generative chemistry to design safer, more effective medicines. The
